Accelerating Typhoid Conjugate Vaccine Introduction: What Can Be Learned From Prior New Vaccine Introduction Initiatives?
Clin Infect Dis
; 68(Suppl 2): S171-S176, 2019 03 07.
Article
en En
| MEDLINE
| ID: mdl-30845328
ABSTRACT
The health consequences of typhoid, including increasing prevalence of drug-resistant strains, can stress healthcare systems. While vaccination is one of the most successful and cost-effective health interventions, vaccine introduction can take years and require considerable effort. The Typhoid Vaccine Acceleration Consortium (TyVAC) employs an integrated, proactive approach to accelerate the introduction of a new typhoid conjugate vaccine to reduce the burden of typhoid in countries eligible for support from Gavi, the Vaccine Alliance. TyVAC and its partners are executing a plan, informed by prior successful vaccine introductions, and tailored to the nuances of typhoid disease and the typhoid conjugate vaccine. The iterative process detailed herein summarizes the strategy and experience gained from the first 2 years of the project.
Palabras clave
Texto completo:
1
Colección:
01-internacional
Base de datos:
MEDLINE
Contexto en salud:
1_ASSA2030
/
2_ODS3
/
4_TD
Problema de salud:
1_doencas_transmissiveis
/
2_cobertura_universal
/
2_enfermedades_transmissibles
/
4_typhoid_paratyphoid_fever_enteric_fever
Asunto principal:
Fiebre Tifoidea
/
Vacunas Tifoides-Paratifoides
/
Vacunación
/
Programas de Inmunización
Tipo de estudio:
Risk_factors_studies
Límite:
Humans
País/Región como asunto:
Africa
/
Asia
Idioma:
En
Revista:
Clin Infect Dis
Asunto de la revista:
DOENCAS TRANSMISSIVEIS
Año:
2019
Tipo del documento:
Article
País de afiliación:
Moldova